Company: ATMCW
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001641172-25-023265
Chunk: 31

Company: ALPHATIME ACQUISITION CORP
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 8
Chunk 31
---
5, have
been organizational activities and those necessary to consummate the Initial Public Offering (“IPO”), described below. Following
our IPO, we will not generate any operating revenues until the completion of our initial business combination. We will generate non-operating
income in the form of interest income after the IPO. We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For
the three months ended June 30, 2025, we had a net loss of $127,315, which consists of loss of $290,004 derived from formation and operating
costs offset by income earned on investment held in Trust Account of $162,689.

For
the six months ended June 30, 2025, we had a net loss of $9,346, which consists of loss of $473,406 derived from formation and operating
costs offset by income earned on investment held in Trust Account of $464,060.

For
the three months ended June 30, 2024, we had a net income of $385,370, which consists of loss of $290,467 derived from formation and
operating costs offset by income earned on investment held in Trust Account of $675,837.

For
the six months ended June 30, 2024, we had a net income of $827,635, which consists of loss of $635,370 derived from formation and operating
costs offset by income earned on investment held in Trust Account of $1,463,005.

1

Liquidity
and Capital Resources

On
January 4, 2023, we consummated our IPO of 6,000,000 units (the “Units”), at $10.00 per Unit, generating gross proceeds of
$60,000,000. Simultaneously with the closing of our IPO, we consummated the sale of 370,500 Private Placement Units at a price of $10.00
per Private Placement Unit in a private placement to the Sponsor, generating total gross proceeds of $3,705,000.

On
January 6, 2023, and effective January 9, 2023, the underwriters in our IPO purchased an additional 900,000 Units to exercise its over-allotment
option in full at a purchase price of $10.00 per Unit, generating gross proceeds of $9,